{
  "docId": "019de076-0505-71be-a3a1-1067f47d4f96",
  "docSlug": "246b804be07776f664c6b3d8600daf3e",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 31,
  "pageCount": 39,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide outlines a clinical trial process flow from initial baskets through immune activation to a pivotal phase.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/31",
  "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96",
  "deckJsonHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96.json",
  "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.96,
        "x": 0.02,
        "y": 0.3
      },
      "kind": "diagram",
      "text": "Clinical trial process flow from baskets to pivotal phase",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48369ecc-7cbe-4a0c-bc48-e11031b40826",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.96,
        "x": 0.02,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "A Multicenter, Open-label, Phase 2 Trial Evaluating the Safety and Efficacy of THIO Administered in Sequence with Anti-PD-1 or Anti-PD-L1",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "323cd44d-024b-485e-b7b7-72bbcb84a52a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.2,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1 Dose to be selected from THIO-101 study results",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd184e95-da75-4fda-8533-bc857ab16e7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.55,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "THIO-103 TRIAL (PLANNED)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db257b7c-4cca-4151-ad3b-415badf06d1b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "ac717ab4-212f-45d9-bd82-9f8a2469c312",
      "evidence": "The slide uses a flow diagram to represent the progression of clinical trial stages.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}